SYBX
Price:
$0.74
Market Cap:
$8.66M
Operating as a clinical-stage biopharmaceutical enterprise, Synlogic, Inc. is dedicated to the creation and progression of synthetic biotic therapeutics aimed at addressing metabolic and immunological conditions across the United States. Its robust portfolio features multiple drug candidates: SYNB1618 and SYNB1934, both non-systemically absorbed and orally administered, are progressing through Phase II clinical trials for phenylketonuria. Another oral, non-systemic agent, SYNB1353, is designed to treat homocystinuria. Furthermore, SYNB8802, an orally taken, non-systemic compound, is currently in Phase I trials for managing enteric hyperoxaluria. Beyond oral treatments, the company is also de...[Read more]
Industry
Biotechnology
IPO Date
2015-09-30
Stock Exchange
NASDAQ
Ticker
SYBX
According to Synlogic, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 7.08. This represents a change of 60.43% compared to the average of 4.41 of the last 4 quarters.
The mean historical Current Ratio of Synlogic, Inc. over the last ten years is 10.38. The current 7.08 Current Ratio has changed 6.72% with respect to the historical average. Over the past ten years (40 quarters), SYBX's Current Ratio was at its highest in in the June 2017 quarter at 33.83. The Current Ratio was at its lowest in in the December 2023 quarter at 2.45.
Average
10.38
Median
11.26
Minimum
2.45
Maximum
22.23
Discovering the peaks and valleys of Synlogic, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 53.69%
Maximum Annual Current Ratio = 22.23
Minimum Annual Increase = -62.84%
Minimum Annual Current Ratio = 2.45
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 4.30 | 53.69% |
| 2024 | 2.80 | 14.28% |
| 2023 | 2.45 | -62.84% |
| 2022 | 6.58 | -50.23% |
| 2021 | 13.23 | 2.75% |
| 2020 | 12.87 | -14.38% |
| 2019 | 15.03 | 2.17% |
| 2018 | 14.71 | 52.63% |
| 2017 | 9.64 | -56.63% |
| 2016 | 22.23 | 44.89% |
The current Current Ratio of Synlogic, Inc. (SYBX) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
3.18
5-year avg
5.87
10-year avg
10.38
Synlogic, Inc.’s Current Ratio is greater than Lixte Biotechnology Holdings, Inc. (2.78), greater than Allarity Therapeutics, Inc. (1.23), less than Lexaria Bioscience Corp. (26.88), greater than Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (2.35), greater than Cingulate Inc. (2.55), greater than Curis, Inc. (1.00), greater than Entero Therapeutics, Inc. (0.16), less than Kairos Pharma, Ltd. (10.31), greater than BriaCell Therapeutics Corp. (7.07), greater than Processa Pharmaceuticals, Inc. (0.98),
| Company | Current Ratio | Market cap |
|---|---|---|
| 2.78 | $71.84M | |
| 1.23 | $22.75M | |
| 26.88 | $12.56M | |
| 2.35 | $10.64M | |
| 2.55 | $27.36M | |
| 1.00 | $5.55M | |
| 0.16 | $13.58M | |
| 10.31 | $9.42M | |
| 7.07 | $5.22M | |
| 0.98 | $4.92M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Synlogic, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Synlogic, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Synlogic, Inc.'s Current Ratio?
How is the Current Ratio calculated for Synlogic, Inc. (SYBX)?
What is the highest Current Ratio for Synlogic, Inc. (SYBX)?
What is the 3-year average Current Ratio for Synlogic, Inc. (SYBX)?
What is the 5-year average Current Ratio for Synlogic, Inc. (SYBX)?
How does the current Current Ratio for Synlogic, Inc. (SYBX) compare to its historical average?